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Epiderm.al Calm.odulin Levels in Psoriasis 
To the Editor: 
Recently, we measured the calmodulin level in lesional psoriatic 
skin vs normal epiderm is [1]. T he protein content of epidermal 
homogenates was estim ated by the method of Lowry et al [2]. 
The va lues were as fo ll ows: (1) Using 0.1 mM CaClz containing 
50 mM Tris-H C I buffer: in normal skin the calmodulin activity 
was 1.05 ± 0.31 p..g ca lmodulin m g - I epidermal protein 
(mean ± SEM, n = 9 volunteers), in psoriatic lesions 2.28 ± 0.69 
(n = 7 patients); (2) using 0.5 l1lM EGTA containing 50 mM Tris-
Hel buffer: 1.3 . ± 0.30 and 2.28 ± 1.08, respectively. 
This underlin es the findin gs o f Mac N eil and Tucker [3] in-
dica ting that the Lowry protein assay is recommended . Further-
more, changing the ca lcium content of the buffer used does not 
result in changin g the ca lmodulin activity significa ntl y. 
Biologica lly act ive ca lmodulin in the pso riatic plague is elevated 
2-fold . T he strikin g difference to ea rlier reports by Tucker et al 
[4) and van de K erkh of and van Erp [5] is caused by methodologic 
discrepancies. 
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REPLY 
We are pleased that Wollina, Klin ger, and Wetzker confirm a 
2-fold elevation in epidermal calmodulin activity in patients with 
psoriasis. 
T his is now the fourth independent g roup (from as many coun-
tries) to report an increase in epiderm al ca lm od ulin levels in pso-
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riasis of the ord er of2- to 3-fold : Mac N eil et al (36 patients) [1) , 
Fai rley et al (9 patients) [2], and Mizumato et al (8 patients) [3]. 
Similar va lues are obtained whether ca lmodulin levels are deter-
mined by radioimmunoassay or by activity assay for calmodulin . 
(Our ea rlier preliminary report of a 6- fold elevation in calmodulin 
we now know to be an overestimate based on an inappropriate 
choice of pro tein assay for the skin samples [4] . Also the original 
observation of a 30-fold elevation in epidermal calmodulin [5) has 
not been confirmed to our knowl edge.) 
In the face of such good agreement among the different research 
groups, it would now seem to be time to investigate the relevance 
of this findin g to the etiology of psoriasis. Our data so far show 
a decrease in epidermal calmodulin fo llowing successful trea tment 
for psoriasis [6] and that one of the com mon trea tments for pso-
riasis, dithranol, possesses calmodulin antagonist activity [7] . With 
more groups now studying ca lmodulin in psorias is we hope that 
the in ves tiga tion of the possible role of this protein in psorias is 
proceeds rapidly over the next few years. 
REFERE N CES 
Sheila Mac Neil 
William F. G. Tucker 
Sheffield, U.K. 
I. Mac Neil W, Tucker WFG , Dawson RA , Bleehen SS, Tom linson S: 
The calmodulin content of the epidermis in psoriasis . C lin Sci 
69:681- 686, 1985 
2. Fairley JA , Marcelo CL, Hogan VA, VoorheesJ]: Increased ca lmodulin 
levels in psoriasis and low Caz+ regulated mouse epidermal kerat-
inocyte cultures. J Invest Dermatol 84:195-198, 1985 
3. MiZllmato T, H ashim oto Y, Hirokawa M, O hkuma N , lizuka H. 
O hkawara A: Calmoduli n activities are sign ifican tly increased in 
both uninvo lved and involved epidermis in psoriasis. J Inves t Der-
matol 85:450-452, 1985 
4. M ac N eil S, Tucker WFG: Epidermal calmodulin levels in psoriasis 
(letter). J Invcs t Dcrmatol 85:389, 1985 
5. van de Kerkhof PC M , van Erp PEJ: C almodu lin levels arc grossly 
elevated in the psoriatic lesion. fir J Dermatol 108:217-218, 1983 
6. Tucker WFG, Mac N eil S, Dawson RA , Tomlinson S, Bleehcn SS: 
Ca lmodulin levels in psori as is: the effect of trea tmcnt . Acta Derm 
Vencreol (Stock h) 66:241-244. 1986 
7. Tucker WFG, M ac N ci l S, Dawson RA , Tom linson S, Blcchen SS: 
In vestigation o f the abi li ty of antipsoriatic drugs to inhibit ca lmo-
dulin activity: a possi ble mode of action of dithranol (anthralin) . J 
In vest Dermatol 87:232-235, 1986 
